Oskar Eriksson

529 total citations
17 papers, 351 citations indexed

About

Oskar Eriksson is a scholar working on Immunology, Infectious Diseases and Hematology. According to data from OpenAlex, Oskar Eriksson has authored 17 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Infectious Diseases and 4 papers in Hematology. Recurrent topics in Oskar Eriksson's work include Complement system in diseases (11 papers), COVID-19 Clinical Research Studies (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Oskar Eriksson is often cited by papers focused on Complement system in diseases (11 papers), COVID-19 Clinical Research Studies (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Oskar Eriksson collaborates with scholars based in Sweden, Germany and Denmark. Oskar Eriksson's co-authors include Bo Nilsson, Kristina Nilsson Ekdahl, Camilla Mohlin, Barbro Persson, Miklós Lipcsey, Michael Hultström, Robert Frithiof, Markus Huber‐Lang, Karin Fromell and Anders Eklúnd and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and European Respiratory Journal.

In The Last Decade

Oskar Eriksson

14 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oskar Eriksson Sweden 9 122 111 68 60 43 17 351
Valeria Miotti Italy 11 191 1.6× 51 0.5× 56 0.8× 156 2.6× 44 1.0× 16 505
Xiaorong Ma China 11 62 0.5× 139 1.3× 29 0.4× 84 1.4× 60 1.4× 29 359
Evan S. Vista United States 11 136 1.1× 29 0.3× 37 0.5× 18 0.3× 18 0.4× 13 311
Sara Bindoli Italy 13 126 1.0× 38 0.3× 27 0.4× 134 2.2× 18 0.4× 29 432
Sara Mohamed Egypt 8 276 2.3× 44 0.4× 23 0.3× 32 0.5× 21 0.5× 39 566
Muzaffer Keklık Türkiye 13 71 0.6× 27 0.2× 22 0.3× 168 2.8× 43 1.0× 63 392
Manisha Patwardhan India 12 199 1.6× 25 0.2× 20 0.3× 20 0.3× 22 0.5× 31 430
Mary C. Walsh United States 8 351 2.9× 32 0.3× 30 0.4× 78 1.3× 20 0.5× 12 532
Ashanty M. Melo Ireland 14 251 2.1× 55 0.5× 69 1.0× 16 0.3× 21 0.5× 30 509
Shigeo Nishimata Japan 10 97 0.8× 55 0.5× 26 0.4× 28 0.5× 12 0.3× 36 379

Countries citing papers authored by Oskar Eriksson

Since Specialization
Citations

This map shows the geographic impact of Oskar Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oskar Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oskar Eriksson more than expected).

Fields of papers citing papers by Oskar Eriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oskar Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oskar Eriksson. The network helps show where Oskar Eriksson may publish in the future.

Co-authorship network of co-authors of Oskar Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Oskar Eriksson. A scholar is included among the top collaborators of Oskar Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oskar Eriksson. Oskar Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Eriksson, Oskar, et al.. (2025). Update on protein array screening of the ficolin-3 interactome. Immunobiology. 230(4). 152965–152965.
3.
4.
Häfner, Susanne, Oskar Eriksson, Vivek Anand Manivel, et al.. (2023). Complement and platelets: prothrombotic cell activation requires membrane attack complex–induced release of danger signals. Blood Advances. 7(20). 6367–6380. 18 indexed citations
5.
Halbgebauer, Rebecca, David Alexander Christian Messerer, Anke Schultze, et al.. (2023). Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?. Journal of Innate Immunity. 15(1). 412–427. 2 indexed citations
6.
Nilsson, Bo, Oskar Eriksson, Karin Fromell, Barbro Persson, & Kristina Nilsson Ekdahl. (2023). How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system. Frontiers in Immunology. 13. 1030627–1030627. 1 indexed citations
7.
Nilsson, Bo, Barbro Persson, Oskar Eriksson, et al.. (2022). How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment. Frontiers in Immunology. 13. 840137–840137. 12 indexed citations
8.
Johansson, Linda, et al.. (2022). Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study. Scandinavian Journal of Rheumatology. 51(3). 214–219. 10 indexed citations
9.
Eriksson, Oskar, Joram Huckriede, Bjarne Winther Kristensen, et al.. (2022). Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients. Journal of Clinical Medicine. 11(12). 3419–3419. 2 indexed citations
10.
Lipcsey, Miklós, Barbro Persson, Oskar Eriksson, et al.. (2021). The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Frontiers in Immunology. 12. 627579–627579. 45 indexed citations
11.
Hultström, Michael, Robert Frithiof, Oskar Eriksson, et al.. (2020). Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients. Thrombosis and Haemostasis. 120(12). 1720–1724. 69 indexed citations
12.
Eriksson, Oskar, Camilla Mohlin, Bo Nilsson, & Kristina Nilsson Ekdahl. (2019). The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System. Frontiers in Immunology. 10. 1590–1590. 100 indexed citations
13.
Eriksson, Oskar, Joyce Chiu, Philip J. Hogg, et al.. (2019). Thiol isomerase ERp57 targets and modulates the lectin pathway of complement activation. Journal of Biological Chemistry. 294(13). 4878–4888. 13 indexed citations
14.
Mohebnasab, Maedeh, Oskar Eriksson, Barbro Persson, et al.. (2019). Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics. Frontiers in Immunology. 10. 2539–2539. 18 indexed citations
15.
Eriksson, Oskar. (2017). Canine transmissible venereal tumour. Epsilon Archive for Student Projects (University of Southampton). 5 indexed citations
16.
Eriksson, Oskar, Lena Håkansson, Malgorzata Karawajczyk, & Daniel Garwicz. (2015). Neutrophil CD64 expression – comparison of two different flow cytometry protocols on EPICs MCL and the Leuko64assay on a Celldyn Sapphire haematology analyser. Scandinavian Journal of Clinical and Laboratory Investigation. 75(5). 428–433. 2 indexed citations
17.
Eklúnd, Anders, Oskar Eriksson, Lena Håkansson, et al.. (1988). Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. European Respiratory Journal. 1(9). 832–838. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026